{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:27:50Z","timestamp":1770110870517,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,1]]},"DOI":"10.7759\/cureus.102764","type":"journal-article","created":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T10:17:42Z","timestamp":1769941062000},"source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and Diagnostic Challenges of Cytomegalovirus Colitis in Inflammatory Bowel Disease: A Retrospective Study From a Romanian Tertiary Care Center"],"prefix":"10.7759","author":[{"given":"Sergiu","family":"Frandes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oana","family":"Frandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melania","family":"Macarie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona M","family":"Bataga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izab358","article-title":"Current status of cytomegalovirus colitis among patients with inflammatory bowel disease in China: a questionnaire-based multicenter study","volume":"28","author":"Yang H","year":"2022","unstructured":"Yang H, Qian J. Current status of cytomegalovirus colitis among patients with inflammatory bowel disease in China: a questionnaire-based multicenter study. Inflamm Bowel Dis. 2022, 28:S45-51. 10.1093\/ibd\/izab358","journal-title":"Inflamm Bowel Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i1.17","article-title":"Clinical significance of cytomegalovirus infection in patients with inflammatory bowel disease","volume":"19","author":"Garrido E","year":"2013","unstructured":"Garrido E, Carrera E, Manzano R, Lopez-Sanroman A. Clinical significance of cytomegalovirus infection in patients with inflammatory bowel disease. World J Gastroenterol. 2013, 19:17-25. 10.3748\/wjg.v19.i1.17","journal-title":"World J Gastroenterol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00284-023-03305-0","article-title":"Association between inflammatory bowel disease and viral infections","volume":"80","author":"Dehghani T","year":"2023","unstructured":"Dehghani T, Gholizadeh O, Daneshvar M, et al.. Association between inflammatory bowel disease and viral infections. Curr Microbiol. 2023, 80:195. 10.1007\/s00284-023-03305-0","journal-title":"Curr Microbiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.655","article-title":"Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection","volume":"20","author":"Cannon MJ","year":"2010","unstructured":"Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol. 2010, 20:202-13. 10.1002\/rmv.655","journal-title":"Rev Med Virol"},{"key":"ref5","article-title":"Steroid-refractory inflammatory bowel disease is a risk factor for CMV infection","volume":"20","author":"Ormeci AC","year":"2016","unstructured":"Ormeci AC, Akyuz F, Baran B, et al.. Steroid-refractory inflammatory bowel disease is a risk factor for CMV infection. Eur Rev Med Pharmacol Sci. 2016, 20:858-65.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2016.3763","article-title":"Effects of cytomegalovirus infection on the prognosis of inflammatory bowel disease patients","volume":"12","author":"Zhang WX","year":"2016","unstructured":"Zhang WX, Ma CY, Zhang JG, et al.. Effects of cytomegalovirus infection on the prognosis of inflammatory bowel disease patients. Exp Ther Med. 2016, 12:3287-93. 10.3892\/etm.2016.3763","journal-title":"Exp Ther Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1029401","article-title":"Severe symptomatic primary CMV infection in inflammatory bowel disease patients with low population seroprevalence","volume":"2018","author":"Rowan C","year":"2018","unstructured":"Rowan C, Judge C, Cannon MD, et al.. Severe symptomatic primary CMV infection in inflammatory bowel disease patients with low population seroprevalence. Gastroenterol Res Pract. 2018, 2018:1029401. 10.1155\/2018\/1029401","journal-title":"Gastroenterol Res Pract"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-008-0639-6","article-title":"Acute cytomegalovirus infection is a risk factor in refractory and complicated inflammatory bowel disease","volume":"54","author":"Maher MM","year":"2009","unstructured":"Maher MM, Nassar MI. Acute cytomegalovirus infection is a risk factor in refractory and complicated inflammatory bowel disease. Dig Dis Sci. 2009, 54:2456-62. 10.1007\/s10620-008-0639-6","journal-title":"Dig Dis Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00869.x","article-title":"Cytomegalovirus colitis complicating inflammatory bowel disease","volume":"101","author":"Kandiel A","year":"2006","unstructured":"Kandiel A, Lashner B. Cytomegalovirus colitis complicating inflammatory bowel disease. Am J Gastroenterol. 2006, 101:2857-65. 10.1111\/j.1572-0241.2006.00869.x","journal-title":"Am J Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2022.2088244","article-title":"The diagnosis and management of CMV colitis in IBD patients shows high practice variation: a national survey among gastroenterologists","volume":"57","author":"Goetgebuer RL","year":"2022","unstructured":"Goetgebuer RL, van der Woude CJ, Bakker L, van der Eijk AA, de Ridder L, de Vries AC. The diagnosis and management of CMV colitis in IBD patients shows high practice variation: a national survey among gastroenterologists. Scand J Gastroenterol. 2022, 57:1321-6. 10.1080\/00365521.2022.2088244","journal-title":"Scand J Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000958","article-title":"Toward an algorithm for the diagnosis and management of CMV in patients with colitis","volume":"22","author":"Beswick L","year":"2016","unstructured":"Beswick L, Ye B, van Langenberg DR. Toward an algorithm for the diagnosis and management of CMV in patients with colitis. Inflamm Bowel Dis. 2016, 22:2966-76. 10.1097\/MIB.0000000000000958","journal-title":"Inflamm Bowel Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1086\/339329","article-title":"Definitions of cytomegalovirus infection and disease in transplant recipients","volume":"34","author":"Ljungman P","year":"2002","unstructured":"Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis. 2002, 34:1094-7. 10.1086\/339329","journal-title":"Clin Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.202","article-title":"Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis","volume":"106","author":"Roblin X","year":"2011","unstructured":"Roblin X, Pillet S, Oussalah A, et al.. Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis. Am J Gastroenterol. 2011, 106:2001-8. 10.1038\/ajg.2011.202","journal-title":"Am J Gastroenterol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21275","article-title":"Cytomegalovirus in inflammatory bowel disease: pathogen or innocent bystander?","volume":"16","author":"Lawlor G","year":"2010","unstructured":"Lawlor G, Moss AC. Cytomegalovirus in inflammatory bowel disease: pathogen or innocent bystander?. Inflamm Bowel Dis. 2010, 16:1620-7. 10.1002\/ibd.21275","journal-title":"Inflamm Bowel Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjab052","article-title":"ECCO Guidelines on the prevention, diagnosis, and management of infections in inflammatory bowel disease","volume":"15","author":"Kucharzik T","year":"2021","unstructured":"Kucharzik T, Ellul P, Greuter T, et al.. ECCO Guidelines on the prevention, diagnosis, and management of infections in inflammatory bowel disease. J Crohns Colitis. 2021, 15:879-913. 10.1093\/ecco-jcc\/jjab052","journal-title":"J Crohns Colitis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000000716","article-title":"Cytomegalovirus disease in inflammatory bowel disease: epidemiology and disease characteristics in a large single-centre experience","volume":"28","author":"Bont\u00e0 J","year":"2016","unstructured":"Bont\u00e0 J, Zeitz J, Frei P, et al.. Cytomegalovirus disease in inflammatory bowel disease: epidemiology and disease characteristics in a large single-centre experience. Eur J Gastroenterol Hepatol. 2016, 28:1329-34. 10.1097\/MEG.0000000000000716","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.481","article-title":"Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN","volume":"106","author":"Turner D","year":"2011","unstructured":"Turner D, Travis SP, Griffiths AM, et al.. Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN. Am J Gastroenterol. 2011, 106:574-88. 10.1038\/ajg.2010.481","journal-title":"Am J Gastroenterol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2008.06.002","article-title":"Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNF\u03b1 therapy","volume":"43","author":"D'Ovidio V","year":"2008","unstructured":"D'Ovidio V, Vernia P, Gentile G, et al.. Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNF\u03b1 therapy. J Clin Virol. 2008, 43:180-3. 10.1016\/j.jcv.2008.06.002","journal-title":"J Clin Virol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20131","article-title":"Infliximab and the risk of latent viruses reactivation in active Crohn's disease","volume":"13","author":"Lavagna A","year":"2007","unstructured":"Lavagna A, Bergallo M, Daperno M, et al.. Infliximab and the risk of latent viruses reactivation in active Crohn's disease. Inflamm Bowel Dis. 2007, 13:896-902. 10.1002\/ibd.20131","journal-title":"Inflamm Bowel Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/17562848231159452","article-title":"Is there an optimal sequence of biologic therapies for inflammatory bowel disease?","volume":"16","author":"Bressler B","year":"2023","unstructured":"Bressler B. Is there an optimal sequence of biologic therapies for inflammatory bowel disease?. Therap Adv Gastroenterol. 2023, 16:17562848231159452. 10.1177\/17562848231159452","journal-title":"Therap Adv Gastroenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/458347-prevalence-and-diagnostic-challenges-of-cytomegalovirus-colitis-in-inflammatory-bowel-disease-a-retrospective-study-from-a-romanian-tertiary-care-center","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T10:17:43Z","timestamp":1769941063000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/458347-prevalence-and-diagnostic-challenges-of-cytomegalovirus-colitis-in-inflammatory-bowel-disease-a-retrospective-study-from-a-romanian-tertiary-care-center"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,1]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.102764","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,1]]}}}